ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Amphastar Pharmaceuticals are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Amphastar Pharmaceuticals. The consolidated Value Rank has an attractive rank of 69, which means that the share price of Amphastar Pharmaceuticals is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 69% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 79. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 76. But the consolidated Growth Rank has a low rank of 26, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 74 of its competitors have better growth. ...read more